These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2572036)

  • 1. Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
    Löfdahl CG; Sigvaldasson A; Skoogh BE; Svedmyr N
    Respiration; 1989; 55 Suppl 2():15-9. PubMed ID: 2572036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the bronchodilator effects of broxaterol and salbutamol.
    Casali L; Rossi A; Manazza P; Colombo ML; Zoia MC
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):93-7. PubMed ID: 2900816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration.
    Löfdahl CG; Svedmyr N
    Allergy; 1989 May; 44(4):264-71. PubMed ID: 2544117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
    Chetta A; Garavaldi G; Cuomo A; Gurrieri G; Olivieri D
    Respiration; 1988; 53(4):220-4. PubMed ID: 2902671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
    Perruchoud AP; Bründler H; Godly R; Imhof E; Herzog H
    Respiration; 1987; 51(2):113-8. PubMed ID: 2884706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response comparison of broxaterol and salbutamol pressurized aerosols.
    Simone P; Borgia M; Torre L; Ventresca GP
    Eur J Clin Pharmacol; 1990; 39(6):565-8. PubMed ID: 1982761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol.
    Rampulla C; Corsico R; Majani U; Lodola E
    Respiration; 1985; 47(4):299-302. PubMed ID: 2861630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of broxaterol in bronchial hyperresponsiveness.
    Bianco S
    Respiration; 1989; 55 Suppl 2():20-7. PubMed ID: 2572037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broxaterol: therapeutic trials and safety profile.
    Ziment I
    Respiration; 1989; 55 Suppl 2():28-40. PubMed ID: 2572038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of a new beta 2-agonist (broxaterol) on bronchospasm induced by methacholine (blind study versus salbutamol)].
    Corrias A; Corona GB; Pelosi U; Corda R
    Pediatr Med Chir; 1989; 11(1):61-3. PubMed ID: 2566160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.
    Robuschi M; Simone P; Vaghi A; Ventresca GP; Bianco S
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):101-4. PubMed ID: 2881897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of broxaterol (vs salbutamol) in asthma induced by physical exercise in children].
    Corrias A; Pelosi U; Corona GB; Minelli R; Peri M; Corda R
    Pediatr Med Chir; 1989; 11(2):161-3. PubMed ID: 2569730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis.
    Ullman A; Hedner J; Svedmyr N
    Am Rev Respir Dis; 1990 Sep; 142(3):571-5. PubMed ID: 1975162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilation and beta 2-selectivity of broxaterol in asthmatics: a crossover, single-blind, terbutaline- and placebo-controlled study.
    Petraglia A; Gurrieri G; Scarpitta M; Pisati R; Ansalone D
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):365-70. PubMed ID: 1359998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broxaterol: pharmacological profile of a unique structural feature.
    Della Bella D
    Respiration; 1989; 55 Suppl 2():10-4. PubMed ID: 2572035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma control during and after cessation of regular beta 2-agonist treatment.
    Wahedna I; Wong CS; Wisniewski AF; Pavord ID; Tattersfield AE
    Am Rev Respir Dis; 1993 Sep; 148(3):707-12. PubMed ID: 8103655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of two beta 2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis.
    Giustina A; Malerba M; Bresciani E; Desenzani P; Licini M; Zaltieri G; Grassi V
    J Endocrinol Invest; 1995 Dec; 18(11):847-52. PubMed ID: 8778156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered cardiovascular autonomic regulation after 2-week inhaled salbutamol treatment in asthmatic children.
    Jartti TT; Kaila TJ; Tahvanainen KU; Kuusela TA; Vanto TT; Välimäki IA
    Eur J Pediatr; 1997 Nov; 156(11):883-8. PubMed ID: 9392406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two new beta 2-adrenoceptor agonists, D-2343 and QH 25, studied in asthmatic patients.
    Löfdahl CG; Bengtsson B; Svedmyr K; Svedmyr N
    Allergy; 1982 Jul; 37(5):351-7. PubMed ID: 6127039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.